GLPGF News and Press, Galapagos Genomics Ord From 02/28/22

David Einhorn's 13F stock portfolio value increased from $1.49B to $1.75B this quarter. Greenlight increased Capri Holdings, ODP Group, Livanova, & Victoria’s Secret while reducing Twitter, Concentrix, & EchoStar. They also added Global Payments while dropping AerCap an...

Galapagos NV (GLPG) Q4 2021 Earnings Conference Call February 25, 2022 8:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer Walid Abi-Saab - Chief Medical Officer Michele Manto...

Galapagos NV (GLPG) Q3 2021 Earnings Conference Call November 5, 2021 8:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer Walid Abi-Saab - Chief Medical Officer Michele Manto ...

Galapagos NV (GLPG) Q2 2021 Earnings Conference Call August 6, 2021 08:00 AM ET Company Participants Sofie Van Gijsel - IR Onno van de Stolpe - CEO Dr. Walid Abi-Saab - CMO Bart Filius - COO and President Conference Call Participants Brian Abrahams - RBC Capital Markets Laura Sutcliffe - UBS ...

Galapagos has over $6.2 billion in cash with no debt and a market capitalization of only $4.5 billion. The company has an approved product that is expected to generate €500 million annually in sales in Europe in the medium term. The partnership with biotech giant Gilead dem...

Galapagos NV (GLPG) Q1 2021 Earnings Conference Call May 07, 2021 08:00 AM ET Company Participants Elizabeth Goodwin - VP of IR Onno Van De Stolpe - Co-Founder & CEO Bart Filius - President & COO Walid Abi-Saab - Chief Medical Officer Piet Wigerinck - Chief Scientific Officer Michele ...

Gilead's shares have come down a lot over the last year, once euphoria around Veklury passed. Gilead is well-positioned in HIV and several other markets. The company combines a low valuation with attractive dividend growth properties. For further details see: Gilead Scie...

The following slide deck was published by Galapagos NV in conjunction with this event. For further details see: Galapagos (GLPG) Investor Presentation - Slideshow

Galapagos NV (GLPG) Q4 2020 Earnings Conference Call February 19, 2021 8:00 AM ET Company Participants Elizabeth Goodwin - Vice President, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief...

The world is awash with liquidity as interest rates remain at historic lows. Cheap liquidity is the fuel that will spark the next buyout bing in smaller cap biotech. A diversified ETF specializing in smaller cap biotechs is the perfect vehicle to capitalize on the trend as detaile...